- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry.
- The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients.
- A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
HUG Becomes First European Hospital to Adopt IBM Watson for Genomics
- Swiss healthcare provider Hôpitaux Universitaires Genève (HUG) becomes the first European university hospital to use IBM Watson for Genomics.
- IBM Watson for Genomics leverages AI to provide expertly validated, up-to-date, comprehensive content to enable clinical reporting & precision oncology programs.
- The HUG is Switzerland's leading center for influenza and emerging viral infections, as well as for childhood liver disease and pediatric liver transplantation.
Hôpitaux
Read More
AI in Healthcare Is Exciting, However, It Is No Reason to Overpay For It
Eventually, many conversations about artificial intelligence (AI) include HAL.
An acronym for Heuristically programmed ALgorithmic computer, HAL played a prominent and disconcerting role in Stanley Kubrick’s mind-bending 1968 film 2001: A Space Odyssey. In the film, sentient computer HAL learns that the humans suspect it of being in error and will disconnect it should that error be confirmed. Of course, HAL is having none of that, and terror ensues.
So influential was
Read More
InsightRX Lands $10M for Precision Medicine Dosing at the Point of Care Platform
- InsightRX raises $10M led by HealthX Ventures to accelerate the adoption of its precision dosing at the point of care platform.
- The platform leverages patient-specific data, pharmacology models, and machine learning to understand each patient’s unique pharmacological profile to guide treatment decisions.
- InsightRX plans to use the new funding to deepen its integration capabilities, broaden development across additional therapeutic areas, and continue its expansion into health
Read More
OSF HealthCare Integrates CancerIQ with Epic EHR to Expand Genetics to Primary Care
- OSF HealthCare integrates CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform to reduce cancer disparities and deaths. - OSF has screened nearly 70k patients using CancerIQ’s platform and will be deployed to primary care practices throughout the system. OSF HealthCare, an integrated healthcare network with locations in Illinois and Michigan, has integrated CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform as part of a system-wide population
Read More
Navigating Cancer Lands $26M to Expand Oncology Patient Relationship Management Platform
- Navigating Cancer raises $26M in Series D funding in an over-subscribed round (TTCP) for its comprehensive oncology patient relationship management solution.
- Navigating Cancer’s PRM platform helps providers manage patient interactions, improve the patient experience, and deliver value-based care more effectively – increasing the flow of communications between in-office visits, which, in turn, boosts patient engagement in their own care.
- Funding will enable NC to accelerate innovation of
Read More
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Life Image Launches Real World Imaging for RWE Programs
- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.
- Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies.
- Life Image represents the only company providing large, heterogeneous,
Read More
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
